AU2003301894A1 - Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d) - Google Patents
Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d)Info
- Publication number
- AU2003301894A1 AU2003301894A1 AU2003301894A AU2003301894A AU2003301894A1 AU 2003301894 A1 AU2003301894 A1 AU 2003301894A1 AU 2003301894 A AU2003301894 A AU 2003301894A AU 2003301894 A AU2003301894 A AU 2003301894A AU 2003301894 A1 AU2003301894 A1 AU 2003301894A1
- Authority
- AU
- Australia
- Prior art keywords
- pde4d
- therapeutics
- diagnostics
- diseases associated
- human phosphodiesterase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02024993 | 2002-11-08 | ||
| EP02024993.4 | 2002-11-08 | ||
| PCT/EP2003/011877 WO2004042389A2 (en) | 2002-11-08 | 2003-10-25 | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003301894A8 AU2003301894A8 (en) | 2004-06-07 |
| AU2003301894A1 true AU2003301894A1 (en) | 2004-06-07 |
Family
ID=32309317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003301894A Abandoned AU2003301894A1 (en) | 2002-11-08 | 2003-10-25 | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d) |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003301894A1 (en) |
| WO (1) | WO2004042389A2 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8022058B2 (en) | 2000-05-10 | 2011-09-20 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
| US7879840B2 (en) | 2005-08-25 | 2011-02-01 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
| US7718644B2 (en) | 2004-01-22 | 2010-05-18 | The Trustees Of Columbia University In The City Of New York | Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof |
| JP2006522594A (en) * | 2003-04-10 | 2006-10-05 | デコデ ジェネティックス イーエイチエフ． | Method of using PDE4D in screening for drugs against atherosclerosis |
| US8710045B2 (en) | 2004-01-22 | 2014-04-29 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the ryanodine receptors |
| CA2591924A1 (en) * | 2004-12-16 | 2006-07-06 | The Trustees Of Columbia University In The City Of New York | Phosphodiesterase 4d in the ryanodine receptor complex protects against heart failure |
| US7704990B2 (en) | 2005-08-25 | 2010-04-27 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
| BRPI1007620A2 (en) | 2009-05-12 | 2016-02-23 | Koninkl Philips Electronics Nv | phosphorester 9a, composition, method of data acquisition, and immunoassay for the diagnosis, detection, monitoring, or prognosis of proposed cancer, or for the diagnosis, detection, monitoring, or prognosis of prostate cancer progression. |
| WO2010131195A1 (en) * | 2009-05-12 | 2010-11-18 | Koninklijke Philips Electronics N.V. | Phosphodiesterase 4d7 as prostate cancer marker |
| BRPI1007704A2 (en) * | 2009-05-12 | 2019-12-03 | Koninl Philips Electronics Nv | phosphodiesterase 4d7 (pde4d7), for use as a marker for hormone-sensitive malignant prostate cancer; composition or method of data acquisition or immunoassay to diagnose, detect, monitor or predict hormone-sensitive malignant prostate cancer or to diagnose, detect, monitor or predict progression to hormone-sensitive malignant prostate cancer; use of pde4d7; immunoassay to discriminate between a benign prostate tumor and a hormone-sensitive malignant prostate cancer; method for identifying an individual for eligibility for hormone-sensitive malignant prostate cancer therapy; immunoassay to classify an individual or section of individuals with a hormone-sensitive malignant prostate cancer disease; inhibitory pharmaceutical composition for the treatment or prevention of hormone sensitive malignant prostate cancer; stimulatory pharmaceutical composition; and; use of a pde4d7 protein-specific antibody and / or a pde4d7 protein-specific antibody variant |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000198734A (en) * | 1998-12-30 | 2000-07-18 | Pfizer Inc | Prokinetic agent for treating gastric hypomotility and related disease |
| CA2357950C (en) * | 1998-12-30 | 2013-07-23 | Oligo Therapeutics Inc. | Therapeutic phosphodiesterase inhibitors |
-
2003
- 2003-10-25 WO PCT/EP2003/011877 patent/WO2004042389A2/en not_active Application Discontinuation
- 2003-10-25 AU AU2003301894A patent/AU2003301894A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004042389A2 (en) | 2004-05-21 |
| AU2003301894A8 (en) | 2004-06-07 |
| WO2004042389A3 (en) | 2004-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003251471A1 (en) | Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 5(cxcr5) | |
| AU2003201147A1 (en) | Medical advice expert | |
| AU2003277164A1 (en) | Imaging catheter with indicia and methods of use | |
| AU2003241291A1 (en) | Vascularized human skin equivalent | |
| AU2003276220A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 2a (pde2a) | |
| AU2003301894A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d) | |
| AU2003238339A1 (en) | Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor | |
| AU2003276136A1 (en) | Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) | |
| AU2003229735A1 (en) | Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr) | |
| AU2003283303A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b) | |
| AU2003205627A1 (en) | Diagnostics and therapeutics for diseases associated with gpr72 | |
| AU2003294728A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2) | |
| AU2003274083A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 10a (pde10a) | |
| AU2003288158A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4c (pde4c) | |
| AU2003279361A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7B (PDE7b) | |
| AU2003283427A1 (en) | Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1) | |
| AU2003267380A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a) | |
| AU2003288171A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a3 (pde9a3) | |
| AU2003282087A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A1 (PDE7a1) | |
| AU2003289894A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a4 (pde9a4) | |
| AU2003279323A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b) | |
| AU2003274082A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4a (pde4a) | |
| AU2003239589A1 (en) | Eta-1 gene and methods for use | |
| AU2003279322A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a3 (pde11a3) | |
| AU2003283302A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a1 (pde11a1) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |